FindTrial
Sign In

Erythropoitin to neuropritection in babies who didnt cry immediately after birth.

Erythropoietin for neuroprotection in term babies with Perinatal asphyxia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/08/035512
Enrollment
100
Registered
2021-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P916- Hypoxic ischemic encephalopathy [HIE]

Interventions

Intervention1: Inj. Erythropoietin: Inj. Erythropoietin 1000u/Kg once daily for 5 days Control Intervention1: Normal Saline: 2 ml

Sponsors

DrSushma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Term Babies with birth asphyxia with PEPA score above 30 within 6 hrs of life

Exclusion criteria

Exclusion criteria: Babies less than 36 weeks of gestation, Babies with major congenital anomalies.

Design outcomes

Primary

MeasureTime frame
General Movement Assessment at 3 months of life.Timepoint: General Movement Assessment at 3 months of life.—

Secondary

MeasureTime frame
All cause mortality at time of dischargeTimepoint: All cause mortality at time of discharge—

Countries

India

Contacts

Public ContactDrSushma

JSS Academy of Higher Education and Research

drsushmasri@gmail.com9742299896

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026